Role of Nox inhibitors plumbagin, ML090 and gp91ds-tat peptide on homocysteine thiolactone induced blood vessel dysfunction
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Nox inhibitors plumbagin, ML090 and gp91ds-tat peptide on homocysteine thiolactone induced blood vessel dysfunction
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 42, Issue 8, Pages 860-864
Publisher
Wiley
Online
2015-05-22
DOI
10.1111/1440-1681.12427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK
- (2016) Ehtesham Shafique et al. Aging-US
- Endothelial NADPH oxidases: which NOX to target in vascular disease?
- (2014) Grant R. Drummond et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: From Pathophysiology to Prevention and Treatment Based on Long-Acting Nitric Oxide Donors
- (2013) P. Kruzliak et al. AMERICAN JOURNAL OF HYPERTENSION
- Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance-Related Endothelial Cell Dysfunction
- (2013) P. Sukumar et al. DIABETES
- Endothelial dysfunction over the course of coronary artery disease
- (2013) E. Gutierrez et al. EUROPEAN HEART JOURNAL
- Inhibition of Nuclear Nox4 Activity by Plumbagin: Effect on Proliferative Capacity in Human Amniotic Stem Cells
- (2013) Marianna Guida et al. Oxidative Medicine and Cellular Longevity
- Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension
- (2012) Peter Kruzliak et al. ANGIOGENESIS
- Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
- (2012) Katrin Schröder et al. CIRCULATION RESEARCH
- Targeting NADPH oxidases in vascular pharmacology
- (2012) Agata Schramm et al. VASCULAR PHARMACOLOGY
- Endothelial Nox4 NADPH Oxidase Enhances Vasodilatation and Reduces Blood Pressure In Vivo
- (2011) Robin Ray et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies
- (2011) Alexander Sirker et al. BASIC RESEARCH IN CARDIOLOGY
- Homocysteine-Induced Apoptosis in Endothelial Cells Coincides With Nuclear NOX2 and Peri-nuclear NOX4 Activity
- (2011) Jessica A. Sipkens et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- eNOS activation and NO function: Structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity
- (2011) Ruslan Rafikov et al. JOURNAL OF ENDOCRINOLOGY
- Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
- (2011) Grant R. Drummond et al. NATURE REVIEWS DRUG DISCOVERY
- A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer Cells
- (2010) Davide Gianni et al. ACS Chemical Biology
- Is oxidative stress a therapeutic target in cardiovascular disease?
- (2010) Thomas Münzel et al. EUROPEAN HEART JOURNAL
- Reactive Oxygen Species, NADPH Oxidases, and Hypertension
- (2010) Srinivasa Raju Datla et al. HYPERTENSION
- High dietary methionine plus cholesterol stimulates early atherosclerosis and late fibrous cap development which is associated with a decrease in GRP78 positive plaque cells
- (2010) Anthony Zulli et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Endothelial dysfunction and cardiovascular risk factors
- (2009) Fernando Grover-Páez et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- High Dietary Taurine Reduces Apoptosis and Atherosclerosis in the Left Main Coronary Artery
- (2009) Anthony Zulli et al. HYPERTENSION
- Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability
- (2009) Gustavo Saposnik et al. STROKE
- NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and Pathophysiology
- (2008) Randall S. Frey et al. ANTIOXIDANTS & REDOX SIGNALING
- More knocks to the oxidation hypothesis for vascular disease?
- (2008) Adam Mullan et al. CLINICAL SCIENCE
- Selective targeting of NADPH oxidase for cardiovascular protection
- (2008) Alison Cave CURRENT OPINION IN PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now